The Psyence Group has built and operates one of the first federally-licensed commercial psilocybin cultivation and production facilities.
The Psyence network, team and operations are located across Toronto (Canada), Washington DC (United States of America), Cape Town (South Africa), Lesotho (Kingdom of Lesotho), Kingston (Jamaica), London (United Kingdom), Sydney (Australia) and Sao Paulo (Brazil).
The company operates in four division:
Psyence Therapeutics: Medicinal formulations and therapies to treat mental health disorders in a clinical environment.
Psyence Production: The first commercially licensed and scalable non-synthetic GMP psilocybin cultivation and processing facility.
Psyence Experience: Premium retreats in Jamaica and Southern Africa reconnect people to nature, nourishing mind and body, and elevating consciousness.
Psyence Function: Industry-leading health and wellbeing products that support the Psyence purpose and are based on proprietary formulations.
Mr. Jody Aufrichtig
Co-Founder & Exec. Chairman
Dr. Neil Maresky
Chief Exec. Officer
Mr. Alan Mark Friedman B.Com., Bcomm, Bproc Law
Co-Founder & Director
Mr. Warwick Corden-Lloyd
Chief Financial Officer
Mr. Mike Dacks
Chief Operating Officer
Dr. Justin Grant M.B.A., Ph.D., MBA
Chief Scientific Officer
Ms. Taryn Vos
Dr. Dingle Spence B.Sc., M.D., MBBS
Chief Medical Officer of Psyence Jamaica & Member of Medical Advisory Board
Mr. Tony Budden
Chief Strategy Officer
Ms. Mary-Elizabeth Gifford
Exec. VP of Public Affairs & Corp. Social Responsibility